纤维化
脂肪性肝炎
肝硬化
生物
斯达
癌症研究
脂肪肝
肝细胞癌
内分泌学
内科学
信号转导
医学
细胞生物学
车站3
疾病
作者
Marcus Grohmann,Florian Wiede,Garron T. Dodd,Esteban N. Gurzov,Geraldine Ooi,Nadeem Hafeez Butt,Aliki A. Rasmiena,Supreet Kaur,Twishi Gulati,Pei Kee Goh,Aislinn E. Treloar,Stuart K. Archer,Wendy A. Brown,Mathias Müller,Matthew J. Watt,Osamu Ohara,Catriona McLean,Tony Tiganis
出处
期刊:Cell
[Elsevier]
日期:2018-10-25
卷期号:175 (5): 1289-1306.e20
被引量:293
标识
DOI:10.1016/j.cell.2018.09.053
摘要
Obesity is a major driver of cancer, especially hepatocellular carcinoma (HCC). The prevailing view is that non-alcoholic steatohepatitis (NASH) and fibrosis or cirrhosis are required for HCC in obesity. Here, we report that NASH and fibrosis and HCC in obesity can be dissociated. We show that the oxidative hepatic environment in obesity inactivates the STAT-1 and STAT-3 phosphatase T cell protein tyrosine phosphatase (TCPTP) and increases STAT-1 and STAT-3 signaling. TCPTP deletion in hepatocytes promoted T cell recruitment and ensuing NASH and fibrosis as well as HCC in obese C57BL/6 mice that normally do not develop NASH and fibrosis or HCC. Attenuating the enhanced STAT-1 signaling prevented T cell recruitment and NASH and fibrosis but did not prevent HCC. By contrast, correcting STAT-3 signaling prevented HCC without affecting NASH and fibrosis. TCPTP-deletion in hepatocytes also markedly accelerated HCC in mice treated with a chemical carcinogen that promotes HCC without NASH and fibrosis. Our studies reveal how obesity-associated hepatic oxidative stress can independently contribute to the pathogenesis of NASH, fibrosis, and HCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI